Cafepharma Today

May 15 2025 - FDA approves Amneal's self-administered migraine treatment
FDA approves Amneal's self-administered migraine treatment
VC firm reveals plan for 30K-square-foot biotech incubator space in New Jersey
Philips taps Nvidia to build AI model for MRI
FDA delays decision on Biohaven's rare disease drug filing, plans adcomm
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Rexahn Pharma Is Considerably Undervalued Based on Prospects, Recent Developments
Seeking Alpha
Monday, January 24, 2011 - 11:12am
tags:
Rexahn, Teva Pharmaceuticals
Eli Lilly's Alzheimer's Diagnostic Steps Closer to Market
Seeking Alpha
Monday, January 24, 2011 - 11:11am
tags:
Eli Lilly, Alzheimer's disease, FDA, florbetapir
Could Social Networking Save Big Pharma?
Forbes
Monday, January 24, 2011 - 11:09am
tags:
social media, Big Pharma
GSK Sets Aside $3.4 Billion Over Avandia Liabilities: Biotech's Latest Tribulations
Seeking Alpha
Monday, January 24, 2011 - 11:09am
tags:
GAK, Avandia, diabetes, legal
FDA pending decision to ease Lap Band restrictions
grinza
Saturday, January 22, 2011 - 11:03am
tags:
lap band surgery, Allergan
Pharmaceutical Sector Remains Genetically Challenged
WSJ
Saturday, January 22, 2011 - 11:00am
tags:
personalized medicine
Merck KgaA, Lead Discovery Centre enter agreement for anti-cancer compounds discovery
Pharmabiz
Saturday, January 22, 2011 - 10:58am
tags:
Merck KGaA, Lead Discovery Centre GmbH, Kinase, cancer
Priority Review for Vertex HCV Drug
Zacks
Saturday, January 22, 2011 - 10:54am
tags:
Vertex Pharmaceuticals, Telaprevir, HCV, hepatitis C
GSK’s US sales tactics undergo radical change
Financial Times, UK
Saturday, January 22, 2011 - 10:52am
tags:
GSK
Foamix Announces Phase II Clinical Trial of Topical Minocycline Foam for Rosacea
PR-USA.net
Saturday, January 22, 2011 - 10:43am
tags:
Foamix, Minocycline, Rosacea
MonoSol Rx, BioDelivery Sciences trade accusations in lawsuit
Fierce Drug Delivery
Saturday, January 22, 2011 - 10:23am
tags:
MonoSol Rx, BioDelivery Sciences, lawsuits
First MS pill may be available soon (in the UK)
Press Assocation News
Saturday, January 22, 2011 - 10:18am
tags:
multiple sclerosis, Gilenya, Novartis
Biotech VC investing grows 3% in 2010
Fierce Biotech
Friday, January 21, 2011 - 12:32pm
tags:
biotech, venture capital
Pfizer, Merck ask court to keep patent deals secret
Fierce Pharma
Friday, January 21, 2011 - 12:29pm
tags:
Pfizer, patents, Merck
Can You Say No to Jiangbo?
Seeking Alpha
Friday, January 21, 2011 - 12:28pm
tags:
Jiangbo Pharmaceuticals, China
Despite Abbott Pullback, DepoMed Still a Value
Seeking Alpha
Friday, January 21, 2011 - 12:27pm
tags:
Abbott Laboratories, Depomed, DM-1796
Showdown time is coming for AZ's Crestor
Fierce Pharma
Friday, January 21, 2011 - 10:15am
tags:
AstraZeneca, Crestor, patents, generics
Acorda, Biogen fall on EU drug rejection
Marketwatch
Friday, January 21, 2011 - 10:13am
tags:
Acorda Therapeutics, Europe, Biogen Idec, Fampyra, MS, multiple sclerosis
Novartis MS Pill Wins European Backing as Rival Acorda Rejected
Bloomberg
Friday, January 21, 2011 - 10:11am
tags:
Novartis, MS, multiple sclerosis, Europe, Acorda Therapeutics, Gilenya, Merck KGaA
Vivus says FDA asks about Qnexa birth defect link
Yahoo/AP
Friday, January 21, 2011 - 10:10am
tags:
Qnexa, birth defects, FDA, Vivus, obesity

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline
The GLP-1 Saga Continues, And How
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.